The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Insulin Secretion and Insulin Resistance in Pregnancy and GDM: Implications for Diagnosis and Management
Abstract
Glucose tolerance deteriorates in human pregnancy, but ∼97–98% of all pregnant women retain a normal glucose tolerance, and only 2–3% develop gestational diabetes mellitus (GDM). Both nondiabetic pregnant women and women with GDM exhibit much higher insulin responses to oral or intravenous administration of glucose or amino acids than found in the nonpregnant state, and the insulin responses to a protein-rich meal are also significantly enhanced in pregnancy. Both quantitative and qualitative differences in insulin secretion exist between pregnant women with normal glucose tolerance (NGT) and women with GDM. Insulin responses to oral glucose and protein-rich meals are thus lower in pregnant women with GDM than in women with NGT, despite significantly higher mean plasma glucose concentrations in the women with GDM. Furthermore, peak plasma insulin concentrations occur later in women with GDM than in pregnant control subjects. Finally, a reduced first-phase insulin response to intravenous glucose can be observed in some women with GDM. Impairment of glucose tolerance in pregnancy is not related to a disproportional secretion of proinsulin nor is increased insulin degradation involved. These observations point to pregnancy as a state of peripheral insulin resistance. Because insulin-receptor binding is only slightly changed in pregnancy and not significantly different in pregnant women with NGT and women with GDM, it follows that the insulin resistance is located at the postreceptor level. Insulin-clamp and “minimal model” studies have shown that the whole-body insulin sensitivity is similarly reduced by about two-thirds of nonpregnant values in pregnant women with NGT and women with GDM. The insulin sensitivity is restored postpartum in the pregnant women with NGT and most of the women with GDM, but about one-third of the women with GDM retain a reduced insulin sensitivity. The insulin resistance in pregnancy is predominantly located in the muscle tissue, where a reduced activity of certain key enzymes in glucose and lipid metabolism has been demonstrated. The insulin resistance is compensated by a considerable increase in insulin secretion, and hence most pregnant women are able to retain NGT. However, some women do not have the capacity to increase their insulin secretion to such an extent that the increased peripheral resistance can be overcome; these are the women who develop GDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GIP increases insulin receptor affinity and cellular sensitivity in adipocytes
Starich, G. H., Bar, R. S., & Mazzaferri, E. L. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.249.6.e603 · Cited by 56 · cited 1×
“polypeptide exerts an increase (55), but this hormone is decreased during pregnancy (15).”
Background
Cited by
Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes
Ben‐Haroush, A., Yogev, Y., & Hod, M. (2004) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00985.x · Cited by 856
A Prospective Study of Pregravid Determinants of Gestational Diabetes Mellitus
Solomon, C. G. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550130052036 · Cited by 787
Pregnancy: a stress test for life
Williams, D. (2003) · Current Opinion in Obstetrics and Gynecology · doi:10.1097/00001703-200312000-00002 · Cited by 346
The thrifty phenotype as an adaptive maternal effect
Wells, J. C. K. (2007) · Biological Reviews · doi:10.1111/j.1469-185x.2006.00007.x · Cited by 278
Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?
RODIE, V (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.038 · Cited by 275
Lipid Metabolism During Pregnancy and its Implications for Fetal Growth
Herrera, E., & Ortega-Senovilla, H. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666140330192345 · Cited by 271
Hebert, M., Ma, X., Naraharisetti, S., Krudys, K., Umans, J., Hankins, G., Caritis, S., Miodovnik, M., Mattison, D., Unadkat, J., et al. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.5 · Cited by 252
Insulin Secretion during and after Pregnancy in Patients with Gestational Diabetes Mellitus1
Homko, C., Sivan, E., Chen, X., Reece, E. A., & Boden, G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7137 · Cited by 217
Metabolic effects of contraceptive steroids
Sitruk-Ware, R., & Nath, A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9182-4 · Cited by 161
Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake
Campbell, S. E., & Febbraio, M. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00184.2001 · Cited by 142
Mathiesen, E. R., Christensen, A. L., Hellmuth, E., Hornnes, P., Stage, E., & Damm, P. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810906.x · Cited by 100
First-phase insulin secretion: can its evaluation direct therapeutic approaches?
Di Giuseppe, G., Ciccarelli, G., Soldovieri, L., Capece, U., Cefalo, C. M. A., Moffa, S., Nista, E. C., Brunetti, M., Cinti, F., Gasbarrini, A., et al. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.02.001 · Cited by 46
“glucose levels because several conditions including obesity [27,28], pregnancy [29,30], and polycystic ovary syndrome [31] are characterized by insulin resistance, increased insulin secretion, and increased β cell mass without hyperglycemia.”
Mizuno, S., Nishigori, H., Sugiyama, T., Takahashi, F., Iwama, N., Watanabe, Z., Sakurai, K., Ishikuro, M., Obara, T., Tatsuta, N., et al. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.020 · Cited by 42
Gestational Diabetes: An Update 60 Years After O’Sullivan and Mahan
McIntyre, H. D., Kampmann, U., Dalsgaard Clausen, T., Laurie, J., & Ma, R. C. W. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae709 · Cited by 32
Tomkins, C. C., Mottola, M. F., & Giroux, I. (2007) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h07-117 · Cited by 4
Metadata
- Authors
- Kühl, C.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1991-12-01
- Volume
- 40
- Issue
- Supplement_2
- Pages
- 18-24
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2172261753
- Cited by
- 207
- References
- 1
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.